Microcap Ledger

Tickers · $HSCS

HeartSciences Inc. $HSCS

By Microcap Ledger desk · CIK 0001468492

Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange
Nasdaq Capital Market
Sector
Finance Services
Headquarters
Southlake, TX
Fiscal year end
April 30
Shares outstanding
4,800,172 [10-Q 2026-09-14]
as of 2026-09-11

Sources: [10-K 2026-07-23]

What the company doesAI summary of filing

HeartSciences Inc. is a healthcare information technology company that develops and commercializes electrocardiography (ECG) software and devices integrated with artificial intelligence algorithms. The company's primary product is MyoVista Insights™, a cloud-based ECG management platform classified as a Medical Device Data System that is exempt from FDA 510(k) clearance and designed to streamline ECG workflows and host multiple AI-ECG algorithms. The company also develops the MyoVista wavECG device, a 12-lead ECG system that was submitted to the FDA for 510(k) clearance in December 2025 and remains under review. HeartSciences is pre-revenue, expects to generate revenue from software installation fees, SaaS usage fees, and marketplace fees for AI-ECG algorithms, and will require additional funding for continued development and commercialization. [10-K 2026-07-23]

Segments: MyoVista Insights™ (ECG management platform), MyoVista wavECG (12-lead ECG device)

Financial health

From XBRL company facts (USD)
PeriodRevenueNet incomeOperating cash flowCashFiling
3 months to Jul 2026$2.1K−$3.17M −$1.32M$29.9K[10-Q 2026-09-14]
FY ended Apr 2026$4.3K−$9.14M −$7.43M$1.66M[10-K 2026-07-23]
FY ended Apr 2025$4.3K−$8.77M −$7.41M$1.10M[10-K 2026-07-23]
Quarterly cash burn
−$1.32M
Cash runway Estimate
~0.1 months

Estimate: cash at the end of the period (3 months to Jul 2026) divided by the average monthly operating cash outflow over that period. Ignores any cash raised or spent since, and any financing.

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
DateShares outstandingFiling
2024-12-12980,321[10-Q 2024-12-16]
2025-03-121,080,946[10-Q 2025-03-13]
2025-07-231,934,280[10-K 2025-07-24]
2025-09-102,647,712[10-Q 2025-09-11]
2025-12-123,178,207[10-Q 2025-12-15]
2026-03-163,184,700[10-Q 2026-03-16]
2026-07-203,899,491[10-K 2026-07-23]
2026-09-114,800,172[10-Q 2026-09-14]
Shelf registration
S-3 filed 2026-09-25; no effectiveness notice found in EDGAR [S-3 2026-09-25]

Listing status

Current status: 4 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-08-07. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.

DateEventDetailsDeadlineFiling
2026-08-078-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2026-08-07]
2025-09-178-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2025-09-17]
2025-05-198-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2025-05-19]
2025-03-218-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2025-03-21]

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
DateInsiderTypeSharesPriceFiling
2026-06-22Simpson Andrewgrant425,000—[4 2026-06-24]
2025-11-28Simpson Andrewgrant70,000—[4 2025-11-28]

Catalysts and calendar

Facts as of . Small caps move fast; check the latest filings.